Search Results
Current treatment approaches in ET and an insight into the SURPASS-ET trial
The SURPASS-ET study: evaluating novel treatment approaches in ET
EXCEED-ET: ropeginterferon alfa-2b in adults with essential thrombocythemia
Unmet needs and therapeutic strategies in essential thrombocythemia
Advances in the science and treatment of MPNs
Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa
Promising trials in polycythemia vera
ANAGRELIDE - Short Review - By Dr. Pramil Cheriyath MD
Ropeginterferon alpha-2b as an effective treatment against PV
10 facts MPN patients need to know about FDA approval of Ropegylated interferon alpha2b (Besremi).
Essential Thrombocythemia Watch & Wait | What Patients Should Know
Managing thrombotic and bleeding complications in patients with MPNs
